ORTEXORTEX News
Tracking ADEA? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AD
Earnings PreviewADEA

Adeia Shorts Retreat as Bulls Eye $200M Revenue Target

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 3 Nov 2026, 04:55

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Adeia Inc. heads into its November 5 earnings report with short sellers quietly stepping back even as the stock has shed a fifth of its value over the past month.

The short-selling picture has turned notably less aggressive in recent weeks. Short interest has fallen roughly 6% over the past week to 6.2% of the free float, and is down about 9% from a month ago, a sustained unwind rather than a one-day adjustment. The lending market reinforces that read: availability is at 681%, meaning there is more than six times as much stock available to borrow as there is currently shorted, well above the 52-week floor of 394%. Borrowing costs are low at 0.48%, despite a modest month-on-month uptick. Options traders are equally relaxed, with the put/call ratio at 0.19, barely above its 20-day average of 0.19 and a long way from the 52-week peak of 1.86. None of the usual signals of pre-earnings anxiety are present.

That calm in positioning sits against a stock that has fallen sharply. ADEA closed at $20.67 on November 2, down 20% over the past month and off 4% on the day, a decline that has compressed the price well below the two active analyst targets sitting at $40 and $50 respectively. The bull case rests on the durability of Adeia's IP licensing base, with the Charter Communications renewal reducing litigation overhang, accelerating adoption of hybrid bonding in semiconductors, and management's stated confidence in a $200 million revenue target. The appointment of Dipti Vachani as CEO brings semiconductor-industry credibility that supporters argue could accelerate the semiconductor licensing arm specifically. Bears counter that the entire model depends on patent protection that is finite. Patent invalidation or expiry opens the licensing base to competitive pressure, squeezing the margins that make the business work. With revenue heavily concentrated in IP monetization, any erosion of the patent portfolio hits the income statement directly.

Institutional ownership tells a broadly constructive story. BlackRock added 596,000 shares in the September quarter, lifting its stake to 15.8% of shares outstanding. Columbia Management added 358,000 shares in the same period to reach 12.4%. T. Rowe Price made the most pointed move, adding nearly 4 million shares to reach 3.7%, a significant build relative to prior position. The insider register is quieter on the open-market side: the October trades were tax-withholding transactions (type F) from the Chief Legal Officer and Chief Licensing Officer, not discretionary sales. The most notable filing was a grant of 173,740 shares to new CEO Vachani in October, an alignment mechanism rather than a market signal.

What the print will test is whether Adeia's licensing renewal pipeline, specifically progress toward the $200 million revenue target, is holding up well enough to explain why the stock has re-rated so sharply lower even as short sellers have been reducing exposure.

Stocks in this article

See the live data behind this article on ORTEX.

Open ADEA on ORTEX →

How this article was generated

Generated
3 Nov 2026, 05:49
Data as of
3 Nov 2026, 04:55
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.